ES2168240T1 - Uso de efectores del sistema nervioso central colinergico para el tratamiento del delirio. - Google Patents

Uso de efectores del sistema nervioso central colinergico para el tratamiento del delirio.

Info

Publication number
ES2168240T1
ES2168240T1 ES99955589T ES99955589T ES2168240T1 ES 2168240 T1 ES2168240 T1 ES 2168240T1 ES 99955589 T ES99955589 T ES 99955589T ES 99955589 T ES99955589 T ES 99955589T ES 2168240 T1 ES2168240 T1 ES 2168240T1
Authority
ES
Spain
Prior art keywords
treatment
nervous system
central nervous
colinergic
effectives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES99955589T
Other languages
English (en)
Other versions
ES2168240T3 (es
Inventor
Peter Fischer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanochemia Pharmazeutika AG
Original Assignee
Sanochemia Pharmazeutika AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanochemia Pharmazeutika AG filed Critical Sanochemia Pharmazeutika AG
Publication of ES2168240T1 publication Critical patent/ES2168240T1/es
Application granted granted Critical
Publication of ES2168240T3 publication Critical patent/ES2168240T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

Uso de efectores del sistema nervioso central colinérgico para la elaboración de una preparación para el tratamiento de delirio de carácter no anticolinérgico.
ES99955589T 1998-11-27 1999-11-22 Uso de inhibidores de aceticolina-esterasa para tratar delirios. Expired - Lifetime ES2168240T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT199598 1998-11-27

Publications (2)

Publication Number Publication Date
ES2168240T1 true ES2168240T1 (es) 2002-06-16
ES2168240T3 ES2168240T3 (es) 2003-11-16

Family

ID=3525562

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99955589T Expired - Lifetime ES2168240T3 (es) 1998-11-27 1999-11-22 Uso de inhibidores de aceticolina-esterasa para tratar delirios.

Country Status (9)

Country Link
EP (1) EP1133290B1 (es)
JP (1) JP4422342B2 (es)
AU (1) AU768331B2 (es)
CA (1) CA2352564C (es)
DE (1) DE59904564D1 (es)
ES (1) ES2168240T3 (es)
GR (1) GR20010300072T1 (es)
NZ (1) NZ512546A (es)
WO (1) WO2000032185A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10301851A1 (de) * 2003-01-17 2004-07-29 Lts Lohmann Therapie-Systeme Ag Verfahren zur medikamentösen Prophylaxe gegen Vergiftungen durch Cholinesterase-Hemmer, sowie hierfür geeignete Wirkstoffe und Arzneimittel
CA2506282A1 (en) * 2003-09-29 2005-04-07 Sanochemia Pharmazeutika Ag Use of galanthamine and the derivatives thereof in the production of medicaments
AT414125B (de) * 2003-09-29 2006-09-15 Sanochemia Pharmazeutika Ag Neue derivate des 4a,5,9,10,11,12-hexahydro- benzofuro(3a,3,2)(2) benzazepin, verfahren zu deren herstellung sowie deren verwendung zur herstellung von arzneimitteln
US20080114027A1 (en) * 2006-11-09 2008-05-15 Johnson Kirk W Method for treating delirium

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0821957A3 (en) * 1996-08-01 1998-04-22 Eli Lilly And Company Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (xanomeline) for treating substance abuse
WO1998017214A1 (en) * 1996-10-23 1998-04-30 Eli Lilly And Company Method for treating dementia due to aids
WO1998031356A1 (en) * 1997-01-17 1998-07-23 Takeda Chemical Industries, Ltd. Idebenone containing combination agent for treating alzheimer's disease

Also Published As

Publication number Publication date
JP4422342B2 (ja) 2010-02-24
AU1252900A (en) 2000-06-19
WO2000032185A1 (de) 2000-06-08
CA2352564A1 (en) 2000-06-08
EP1133290B1 (de) 2003-03-12
CA2352564C (en) 2009-05-19
EP1133290A1 (de) 2001-09-19
JP2002531401A (ja) 2002-09-24
GR20010300072T1 (en) 2001-12-31
ES2168240T3 (es) 2003-11-16
AU768331B2 (en) 2003-12-11
NZ512546A (en) 2002-11-26
DE59904564D1 (de) 2003-04-17

Similar Documents

Publication Publication Date Title
ATE340171T1 (de) Piperazinderivate zur behandlung bakterieller infektionen
UY26380A1 (es) Inhibidores de fab i
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
MXPA02007915A (es) Mediador de lipido activado por aspirina.
SV1999000194A (es) Preparado farmaceuticio de moxifloxacina ref. lea 33327-sv
EE200300212A (et) Ravimite kombinatsioonid (näiteks kloorpromasiin ja pentamidiin) neoplastiliste haiguste raviks
PT1143967E (pt) Utilizacao de derivados anticonvulsivos para o tratamento de cefaleias em salvas
IS6448A (is) Bakteríuskæð 3-amónóqínazólin-2.4díon hrifefni
AR028705A1 (es) Bis-arilsulfonas
BR0010418B1 (pt) microorganismo de salmonella, composiÇço de vacina e uso do referido microorganismo.
BR0015490A (pt) Combinações oncolìticas para o tratamento de câncer
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
ES2178761T3 (es) Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de infe cciones cutaneas.
BR0114379A (pt) Derivados de c-ciclohexilmetilamina substituìdos
AR030662A1 (es) Beta-tio-alfa-aminoacidos, procedimiento para su fabricacion, medicamentos que contienen estos compuestos y el uso de los tioaminoacidos para la preparacion de medicamentos
ES2168240T1 (es) Uso de efectores del sistema nervioso central colinergico para el tratamiento del delirio.
TR200402230T4 (tr) O-ikameli 6-metil-tramadol-türevleri
TR200103125T2 (tr) Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri.
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
IT1289154B1 (it) Derivati di isoflavone loro preparazione e loro impiego terapeutico
ES2144857T3 (es) Utilizacion de derivados benzonaftalenicos para la fabricacion de medicamentos destinados para el tratamiento de las enfermedades del sistema nervioso.
PT1305307E (pt) Derivados de indole eficazes no tratamento de doencas do sistema nervoso central
PT1212119E (pt) Utilizacao de ciamemazina no tratamento do desmame subito de benzodiazepinas
DE60010934D1 (de) Medikamente geeignet zur Behandlung von proliferativen Erkrankungen